Compare CWST & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWST | TWST |
|---|---|---|
| Founded | 1975 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.2B |
| IPO Year | 1997 | 2018 |
| Metric | CWST | TWST |
|---|---|---|
| Price | $89.39 | $90.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $115.71 | $46.88 |
| AVG Volume (30 Days) | 642.0K | ★ 1.5M |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,836,841,000.00 | $376,572,000.00 |
| Revenue This Year | $10.95 | $18.91 |
| Revenue Next Year | $6.97 | $15.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 17.95 | ★ 20.32 |
| 52 Week Low | $74.05 | $23.30 |
| 52 Week High | $111.48 | $105.47 |
| Indicator | CWST | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 42.76 | 52.65 |
| Support Level | $83.41 | $86.30 |
| Resistance Level | $90.35 | $105.47 |
| Average True Range (ATR) | 3.22 | 6.31 |
| MACD | -1.25 | -1.21 |
| Stochastic Oscillator | 7.76 | 38.28 |
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.